Effect of nitric oxide synthase inhibition on postischemic cerebral hyperemia

Robert S Greenberg, M. A. Helfaer, J. R. Kirsch, R. J. Traystman

Research output: Contribution to journalArticle

Abstract

We tested the hypothesis that inhibition of nitric oxide synthase (NOS) activity in brain before ischemia decreases postischemic hyperemia. Pentobarbital-anesthetized piglets underwent 15 min of complete global cerebral ischemia induced by elevation of intracranial pressure followed by 20 min of reperfusion. Before ischemia the animals were randomly assigned to receive either intravenous N(ω)-nitro-L-arginine methyl ester (L-NAME 10 mg/kg, n = 6, or 50 mg/kg, n = 6) or an equal volume of saline (10 ml, n = 8). Serial cerebral blood flow (radiolabeled microspheres) was measured at baseline and during ischemia and reperfusion. Forebrain postischemic hyperemia was documented after administration of saline (42 ± 4 to 88 ± 10 ml · min-1 · 100 g-1) and 10 mg/kg L-NAME (36 ± 4 to 59 ± 9 ml · min-1 · 100 g-1) but not after 50 mg/kg L-NAME (29 ± 3 to 34 ± 7 ml · min-1 · 100 g-1). However, the percent reduction in cerebral vascular resistance (CVR) fell during reperfusion to a similar extent in all three groups because of differences between groups in cerebral perfusion pressure changes during the protocol. CVR fell to the lowest level at 8 min of reperfusion in the saline-treated animals (2.0 ± 0.16 to 0.68 ± 0.05 mmHg · ml-1 · min · 100 g) compared with the L-NAME-treated animals (50 mg/kg: 4.0 ± 0.3 to 1.8 ± 0.2 mmHg · ml-1 · min · 100 g). Brain NOS activity increased over time in the saline-treated animals (n = 4, maximum 152 ± 29% of baseline at 15 min) but decreased in a dose-related manner after 10 mg/kg (n = 4, 59 ± 27% of baseline at 15 min) and 50 mg/kg L-NAME (n = 5, 10 ± 3% of baseline at 15 min). These results suggest that inhibition of NOS with L-NAME has an effect on early (

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume269
Issue number1 38-1
StatePublished - 1995

Fingerprint

NG-Nitroarginine Methyl Ester
Hyperemia
Nitric Oxide Synthase
Reperfusion
Cerebrovascular Circulation
Brain Ischemia
Vascular Resistance
Ischemia
Intracranial Hypertension
Pentobarbital
Prosencephalon
Microspheres
Brain

Keywords

  • cerebral blood flow
  • cerebral oxygen consumption
  • ischemia
  • piglets
  • reperfusion

ASJC Scopus subject areas

  • Physiology

Cite this

Effect of nitric oxide synthase inhibition on postischemic cerebral hyperemia. / Greenberg, Robert S; Helfaer, M. A.; Kirsch, J. R.; Traystman, R. J.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 269, No. 1 38-1, 1995.

Research output: Contribution to journalArticle

@article{6441975193734e4bb1762db7592baa71,
title = "Effect of nitric oxide synthase inhibition on postischemic cerebral hyperemia",
abstract = "We tested the hypothesis that inhibition of nitric oxide synthase (NOS) activity in brain before ischemia decreases postischemic hyperemia. Pentobarbital-anesthetized piglets underwent 15 min of complete global cerebral ischemia induced by elevation of intracranial pressure followed by 20 min of reperfusion. Before ischemia the animals were randomly assigned to receive either intravenous N(ω)-nitro-L-arginine methyl ester (L-NAME 10 mg/kg, n = 6, or 50 mg/kg, n = 6) or an equal volume of saline (10 ml, n = 8). Serial cerebral blood flow (radiolabeled microspheres) was measured at baseline and during ischemia and reperfusion. Forebrain postischemic hyperemia was documented after administration of saline (42 ± 4 to 88 ± 10 ml · min-1 · 100 g-1) and 10 mg/kg L-NAME (36 ± 4 to 59 ± 9 ml · min-1 · 100 g-1) but not after 50 mg/kg L-NAME (29 ± 3 to 34 ± 7 ml · min-1 · 100 g-1). However, the percent reduction in cerebral vascular resistance (CVR) fell during reperfusion to a similar extent in all three groups because of differences between groups in cerebral perfusion pressure changes during the protocol. CVR fell to the lowest level at 8 min of reperfusion in the saline-treated animals (2.0 ± 0.16 to 0.68 ± 0.05 mmHg · ml-1 · min · 100 g) compared with the L-NAME-treated animals (50 mg/kg: 4.0 ± 0.3 to 1.8 ± 0.2 mmHg · ml-1 · min · 100 g). Brain NOS activity increased over time in the saline-treated animals (n = 4, maximum 152 ± 29{\%} of baseline at 15 min) but decreased in a dose-related manner after 10 mg/kg (n = 4, 59 ± 27{\%} of baseline at 15 min) and 50 mg/kg L-NAME (n = 5, 10 ± 3{\%} of baseline at 15 min). These results suggest that inhibition of NOS with L-NAME has an effect on early (",
keywords = "cerebral blood flow, cerebral oxygen consumption, ischemia, piglets, reperfusion",
author = "Greenberg, {Robert S} and Helfaer, {M. A.} and Kirsch, {J. R.} and Traystman, {R. J.}",
year = "1995",
language = "English (US)",
volume = "269",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 38-1",

}

TY - JOUR

T1 - Effect of nitric oxide synthase inhibition on postischemic cerebral hyperemia

AU - Greenberg, Robert S

AU - Helfaer, M. A.

AU - Kirsch, J. R.

AU - Traystman, R. J.

PY - 1995

Y1 - 1995

N2 - We tested the hypothesis that inhibition of nitric oxide synthase (NOS) activity in brain before ischemia decreases postischemic hyperemia. Pentobarbital-anesthetized piglets underwent 15 min of complete global cerebral ischemia induced by elevation of intracranial pressure followed by 20 min of reperfusion. Before ischemia the animals were randomly assigned to receive either intravenous N(ω)-nitro-L-arginine methyl ester (L-NAME 10 mg/kg, n = 6, or 50 mg/kg, n = 6) or an equal volume of saline (10 ml, n = 8). Serial cerebral blood flow (radiolabeled microspheres) was measured at baseline and during ischemia and reperfusion. Forebrain postischemic hyperemia was documented after administration of saline (42 ± 4 to 88 ± 10 ml · min-1 · 100 g-1) and 10 mg/kg L-NAME (36 ± 4 to 59 ± 9 ml · min-1 · 100 g-1) but not after 50 mg/kg L-NAME (29 ± 3 to 34 ± 7 ml · min-1 · 100 g-1). However, the percent reduction in cerebral vascular resistance (CVR) fell during reperfusion to a similar extent in all three groups because of differences between groups in cerebral perfusion pressure changes during the protocol. CVR fell to the lowest level at 8 min of reperfusion in the saline-treated animals (2.0 ± 0.16 to 0.68 ± 0.05 mmHg · ml-1 · min · 100 g) compared with the L-NAME-treated animals (50 mg/kg: 4.0 ± 0.3 to 1.8 ± 0.2 mmHg · ml-1 · min · 100 g). Brain NOS activity increased over time in the saline-treated animals (n = 4, maximum 152 ± 29% of baseline at 15 min) but decreased in a dose-related manner after 10 mg/kg (n = 4, 59 ± 27% of baseline at 15 min) and 50 mg/kg L-NAME (n = 5, 10 ± 3% of baseline at 15 min). These results suggest that inhibition of NOS with L-NAME has an effect on early (

AB - We tested the hypothesis that inhibition of nitric oxide synthase (NOS) activity in brain before ischemia decreases postischemic hyperemia. Pentobarbital-anesthetized piglets underwent 15 min of complete global cerebral ischemia induced by elevation of intracranial pressure followed by 20 min of reperfusion. Before ischemia the animals were randomly assigned to receive either intravenous N(ω)-nitro-L-arginine methyl ester (L-NAME 10 mg/kg, n = 6, or 50 mg/kg, n = 6) or an equal volume of saline (10 ml, n = 8). Serial cerebral blood flow (radiolabeled microspheres) was measured at baseline and during ischemia and reperfusion. Forebrain postischemic hyperemia was documented after administration of saline (42 ± 4 to 88 ± 10 ml · min-1 · 100 g-1) and 10 mg/kg L-NAME (36 ± 4 to 59 ± 9 ml · min-1 · 100 g-1) but not after 50 mg/kg L-NAME (29 ± 3 to 34 ± 7 ml · min-1 · 100 g-1). However, the percent reduction in cerebral vascular resistance (CVR) fell during reperfusion to a similar extent in all three groups because of differences between groups in cerebral perfusion pressure changes during the protocol. CVR fell to the lowest level at 8 min of reperfusion in the saline-treated animals (2.0 ± 0.16 to 0.68 ± 0.05 mmHg · ml-1 · min · 100 g) compared with the L-NAME-treated animals (50 mg/kg: 4.0 ± 0.3 to 1.8 ± 0.2 mmHg · ml-1 · min · 100 g). Brain NOS activity increased over time in the saline-treated animals (n = 4, maximum 152 ± 29% of baseline at 15 min) but decreased in a dose-related manner after 10 mg/kg (n = 4, 59 ± 27% of baseline at 15 min) and 50 mg/kg L-NAME (n = 5, 10 ± 3% of baseline at 15 min). These results suggest that inhibition of NOS with L-NAME has an effect on early (

KW - cerebral blood flow

KW - cerebral oxygen consumption

KW - ischemia

KW - piglets

KW - reperfusion

UR - http://www.scopus.com/inward/record.url?scp=0029152957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029152957&partnerID=8YFLogxK

M3 - Article

C2 - 7543258

AN - SCOPUS:0029152957

VL - 269

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 1 38-1

ER -